Vascular Endothelial Growth Factor Expression in Serous Ovarian Carcinoma: Relationship with High Mitotic Activity and High FIGO Stage
- 1 January 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 84 (1) , 47-52
- https://doi.org/10.1006/gyno.2001.6467
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Vascular Endothelial Growth Factor Expression as a Prognostic Index in Serous Ovarian Cystoadenocarcinomas: Relationship with MIB1 ImmunostainingGynecologic Oncology, 1999
- The role of vascular endothelial growth factor in blood vessel formationTrends in Cell Biology, 1996
- Inhibition of Growth and Metastasis of Ovarian Carcinoma by Administering a Drug Capable of Interfering with Vascular Endothelial Growth Factor ActivityJapanese Journal of Cancer Research, 1996
- Vascular Endothelial Growth Factor andde NovoMammalian AngiogenesisMicrovascular Research, 1996
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Ki67 Antigen Immunostaining (MIB 1 Monoclonal Antibody) in Serous Ovarian Tumors: Index of Proliferative Activity with Prognostic SignificanceGynecologic Oncology, 1995
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast CancerJapanese Journal of Cancer Research, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992